Rivastigmine

Category
Alzheimer Disease
Product code
123441-03-2

Rivastigmine is a reversible cholinesterase inhibitor active pharmaceutical ingredient widely used for the treatment of mild to moderate Alzheimer’s disease and Parkinson’s disease dementia. By inhibiting both acetylcholinesterase and butyrylcholinesterase, Rivastigmine increases acetylcholine levels in the brain, enhancing cognitive function, memory, and attention in affected patients. Pharmaceutical companies formulate Rivastigmine into oral capsules, oral solutions, and transdermal patches, providing flexible dosing options and improved patient adherence.

Common Rivastigmine Uses and Treated Conditions

  • Alzheimer’s Disease – Improves cognitive function and daily living activities in patients with mild to moderate disease.
  • Parkinson’s Disease Dementia – Enhances cognition and memory in patients with Parkinson’s-related cognitive decline.
  • Cognitive Symptom Management – Supports attention, memory, and functional abilities in neurodegenerative disorders.

Why Choose Cambrex as Your Generic API Manufacturer?

As a leading generic API supplier, Cambrex manufactures Rivastigmine API in cGMP-compliant facilities, ensuring every batch meets stringent global quality and regulatory standards. Our technical expertise, robust quality systems, and proven regulatory track record empower clients to accelerate development timelines and achieve successful market approvals. We prioritize transparency, reliability, and scientific rigor at every stage of the supply chain making us your trusted generic API manufacturer.

For detailed chemical information on Rivastigmine, visit the official CAS website.

If you’d like more information or to request a sample, contact our Generic API team today.

Rivastigmine

Cambrex your API partner

Cambrex are a leading global supplier of generic APIs. From our sites in Italy, Sweden, and the USA, we work with generic drug companies well in advance of drug patent expiration, using high quality, non-patent-infringing processes to manufacture APIs.

Contact us